GGrantIndex
Sort

15,273 grants matching antimicrobial resistance

Dissecting Yersinia Yop Targets in Neutrophils

$751,946
Joan C. Mecsas · Tufts University Boston · R01 · FY2022 · AI

Improving vaccine development through high-throughput immunogenicity screening.

$751,913
Benjamin Delbert Brooks · Carterra, Inc. · R44 · FY2016 · AI

Improving vaccine development through high-throughput immunogenicity screening.

$751,389
Benjamin Delbert Brooks · Carterra, Inc. · R44 · FY2017 · AI

Repurposing novel selective drugs for treatment and decolonization of vancomycin resistant enterococci

$751,315
Mohamed Seleem · Purdue University · R01 · FY2019 · AI

Rapid Identification of Optimal Combination Regimens for Pseudomonas aeruginosa

$751,274
George Louis Drusano · University Of Florida · R01 · FY2016 · AI

Integrated Multi-omics of Melioidosis

$750,994
Timothy Eoin West · University Of Washington · R01 · FY2018 · AI

Molecular Clonality of Uropathogenic E. Coli

$750,926
Evgeni Veniaminovic Sokurenko · University Of Washington · R01 · FY2022 · AI

Resistance Suppression for P. Aeruginosa using Novel Combination Therapy Modeling

$750,762
George Louis Drusano · Ordway Research Institute, Inc. · R01 · FY2010 · AI

Clinical and molecular epidemiology of the sexual transmission of Neisseria meningitidis

$750,579
Abigail Norris Turner · Ohio State University · R01 · FY2019 · AI

A comprehensive investigation of Pseudomonas quorum sensing regulatory relationships and the consequences on quorum sensing inhibitors in complex communities

$750,050
Laurence G Rahme · Massachusetts General Hospital · R01 · FY2024 · AI

TOPICAL PROTEGRINS TO PREVENT STDS &HIV INFECTION

$750,048
University Of California Los Angeles · P01 · FY2000 · AI

A Novel Therapeutic for Invasive Candidiasis

$750,000
Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2014 · AI

RFA-GH-20-005, Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)

$750,000
Eduardo Gotuzzo · Universidad Peruana Cayetano Heredia · U01 · FY2024 · GH

A Novel Therapeutic for Invasive Candidiasis

$750,000
Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2015 · AI

STTR Phase II: A novel wound dressing for infection control and tissue regeneration

$750,000
Michael Zimber · Histogen, Inc. · · FY2017 · TIP

Project of Febrile Illness Surveillance in the Andean and Amazon Countries (PISAAC)

$750,000
Eduardo Gotuzzo · Universidad Peruana Cayetano Heredia · U01 · FY2022 · GH

A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans

$750,000
Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2018 · AT

PARADIGM SHIFT: REVOLUTIONIZING OUR UNDERSTANDING OF ANTIMICROBIAL RESISTANCE ECOLOGY THROUGH WHOLE GENOME ANALYSIS OF MICROBIAL COMMUNITIES

$749,886
Colorado State University · · FY2016 · National Institute of Food and Agriculture

PARADIGM SHIFT: REVOLUTIONIZING OUR UNDERSTANDING OF ANTIMICROBIAL RESISTANCE ECOLOGY THROUGH WHOLE GENOME ANALYSIS OF MICROBIAL COMMUNITIES

$749,838
Colorado State University · · FY2015 · National Institute of Food and Agriculture

Developing therapeutics to treat chronic infections

$749,804
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2017 · AI

Preclinical development of teixobactin, a new antibiotic

$749,698
Dallas Hughes · Novobiotic Pharmaceuticals, Llc · R44 · FY2015 · AI

PARADIGM SHIFT: REVOLUTIONIZING OUR UNDERSTANDING OF ANTIMICROBIAL RESISTANCE ECOLOGY THROUGH WHOLE GENOME ANALYSIS OF MICROBIAL COMMUNITIES

$749,435
Colorado State University · · FY2017 · National Institute of Food and Agriculture

Mechanism of macrophage efflux system in Mycobacterium tuberculosis pathogenesis

$749,414
Murugesan Rajaram · Ohio State University · R56 · FY2024 · AI

A Scalable Platform to Discover Antimicrobials of Ribosomal Origin

$749,232
Huimin Zhao · University Of Illinois At Urbana-Champaign · R01 · FY2020 · AI

Ultrathin dissolvable antibiofilm wound contact dressing with silver and gallium

$749,150
Ankit Agarwal · Imbed Biosciences, Inc. · R44 · FY2020 · AR